You just read:

FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing

News provided by

LEO Pharma Inc.

Jan 25, 2012, 08:02 ET